ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 131233 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 131233; 2) Community: the network communities that were significantly associated with the response to NSC 131233; 3) Molecule: the relationships between components within communities and NSC 131233; 4) MDR: the compounds that were significantly associated with the NSC 131233.

NSC Compound Enrichment Correlation
NSC 714604 Purpureagitosid 0.0342636096654271 -0.006669698
NSC 722867 Null 0.0342636096654271 0.27106135
NSC 735373 Bis{(5,6-dihydro-5,11-diketo-2,3-dimethoxy-11H-indeno[1,2-c] isoquinoline)-6-propylamino}propane Bis(trifluoroacetate) 0.0342636096654271 0.27886448
NSC 735408 Null 0.0342636096654271 0.44030655
NSC 736041 7-(5-diethylaminopentyloxy)-5-hydroxy-2-phenyl-4H-4-chromeno ne 0.0342636096654271 0.22633536
NSC 749297 N'-{2-[2-(4-Methoxy-phenyl)-vinyl]quinazolin-4-yl}-N,N-dimethyl-propane-1,3-diamine hydrochloride 0.0342636096654271 0.27199198
NSC 763059 Paracymene-ruthenium(II)-[N-(3-(1H-imidazol-1-yl)propyl)-4-(1-(3,5,5,8,8-pentamethyl-5,6,7,8 tetrahydronaphthalen-2-yl)vinyl)benzamide] dichloride 0.0342636096654271 0.069775891
NSC 79093 5-Hydroxy-6,7,8,4'-tetramethoxyflavone 0.0342636096654271 0.14851151
NSC 119875 Cisplatin 0.0342636096654276 0.05144583
NSC 117281 ANTINEOPLASTIC-117281 0.0385203205529754 0.34413131
Total:66  Current:49    [First] [Prev] [Next] [Last]